Institutional Ownership X4 Pharmaceuticals, Inc (XFOR)
This table provides information about the institutional ownership of X4 Pharmaceuticals, Inc (XFOR). We have compiled data on the 97 institutions that hold shares in the stock, with a total of 99.6 Million shares, which have been reported (via 13F filing form) to have a value of $47.8 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
Feb 14, 2025 Q4 2024 |
16,915,784
shares
|
$8.12 Million
3.52% of portfolio
|
Q4 2023
Added 5.98%
|
|
Nea Management Company, LLC
Timonium, MD |
Feb 14, 2025 Q4 2024 |
14,986,793
shares
|
$7.19 Million
0.82% of portfolio
|
Q2 2023
Added 27.69%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
10,675,963
shares
|
$5.12 Million
0.0% of portfolio
|
Q2 2024
Added 22.21%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
8,200,903
shares
|
$3.94 Million
0.0% of portfolio
|
Q4 2024
Reduced 2.84%
|
|
Acorn Capital Advisors, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
7,310,650
shares
|
$3.51 Million
2.9% of portfolio
|
Q4 2024
New holding
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
7,133,515
shares
|
$3.42 Million
0.15% of portfolio
|
Q2 2023
Added 22.62%
|
|
Kingdon Capital Management, L.L.C.
New York, NY |
Feb 14, 2025 Q4 2024 |
4,937,000
shares
|
$2.37 Million
0.62% of portfolio
|
Q4 2024
Added 6.43%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
3,497,212
shares
|
$1.68 Million
0.0% of portfolio
|
Q4 2024
Added 1.44%
|
|
Axa S.A.
Paris, I0 |
Feb 14, 2025 Q4 2024 |
3,072,143
shares
|
$1.47 Million
0.01% of portfolio
|
Q4 2024
Reduced 0.16%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
3,057,297
shares
|
$1.47 Million
0.0% of portfolio
|
Q4 2024
Added 3.54%
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Feb 13, 2025 Q4 2024 |
2,546,458
shares
|
$1.22 Million
0.0% of portfolio
|
Q2 2024
Added 4.56%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Feb 14, 2025 Q4 2024 |
1,887,611
shares
|
$906,053
0.0% of portfolio
|
Q4 2024
Added 992.29%
|
|
Pale Fire Capital Se
Prague, 2N |
Feb 13, 2025 Q4 2024 |
1,401,964
shares
|
$672,942
0.23% of portfolio
|
Q4 2024
Reduced 12.53%
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,392,826
shares
|
$668,556
0.01% of portfolio
|
Q4 2024
Reduced 27.49%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,357,539
shares
|
$651,618
0.0% of portfolio
|
Q4 2024
Added 2.88%
|
|
Gsa Capital Partners LLP
London, X0 |
Feb 07, 2025 Q4 2024 |
1,273,635
shares
|
$611,344
0.07% of portfolio
|
Q4 2024
Added 150.87%
|
|
Ubs Oconnor LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,264,358
shares
|
$606,891
0.06% of portfolio
|
Q4 2024
Reduced 18.39%
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
923,060
shares
|
$443,068
0.0% of portfolio
|
Q4 2024
Added 253.49%
|
|
Group One Trading, L.P.
Chicago, IL |
Feb 14, 2025 Q4 2024 |
797,411
shares
|
$382,757
0.02% of portfolio
|
Q4 2024
Added 535.37%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Feb 14, 2025 Q4 2024 |
650,000
shares
|
$312,000
0.0% of portfolio
|
Q4 2024
Added 3.99%
|
|
Jane Street Group, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
583,483
shares
|
$280,071
0.0% of portfolio
|
Q4 2024
Added 134.85%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
550,495
shares
|
$264,237
0.0% of portfolio
|
Q4 2024
Added 12.19%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
477,638
shares
|
$229,266
0.0% of portfolio
|
Q4 2024
Added 63.25%
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
459,653
shares
|
$220,633
0.0% of portfolio
|
Q4 2024
Added 501.04%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
438,208
shares
|
$210,339
0.0% of portfolio
|
Q2 2024
Added 35.31%
|